Harpoon Therapeutics Inc (DELISTED) (HARP:DL)
23.01
0.00 (0.00%)
USD |
NASDAQ |
Mar 11, 16:00
Harpoon Therapeutics Accounts Payable (Quarterly): 3.435M for Sept. 30, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 3.435M |
| June 30, 2023 | 3.627M |
| March 31, 2023 | 4.002M |
| December 31, 2022 | 4.712M |
| September 30, 2022 | 2.64M |
| June 30, 2022 | 2.79M |
| March 31, 2022 | 4.189M |
| December 31, 2021 | 2.666M |
| September 30, 2021 | 1.598M |
| June 30, 2021 | 1.997M |
| March 31, 2021 | 2.641M |
| Date | Value |
|---|---|
| December 31, 2020 | 1.572M |
| September 30, 2020 | 1.779M |
| June 30, 2020 | 1.586M |
| March 31, 2020 | 1.545M |
| December 31, 2019 | 2.594M |
| September 30, 2019 | 3.90M |
| June 30, 2019 | 4.519M |
| March 31, 2019 | 3.411M |
| December 31, 2018 | 4.357M |
| September 30, 2018 | 1.746M |
| December 31, 2017 | 1.174M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
1.545M
Minimum
Mar 2020
4.712M
Maximum
Dec 2022
2.877M
Average
2.654M
Median
Accounts Payable (Quarterly) Benchmarks
| Merck & Co Inc | 3.514B |
| Axonics Inc | 15.77M |
| Johnson & Johnson | 8.174B |
| Boston Scientific Corp | 921.00M |
| Ambrx Biopharma Inc (DELISTED) | 5.141M |